Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06616025 · ClinicalTrials.gov registry record · Phase 3

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

A Phase 3 study of Peripheral Nerve Injury Upper Limb and Peripheral Nerve Injury (PNI), sponsored by Neuraptive Therapeutics.

Recruiting
Registry status
Phase 3
Development phase
98
Enrollment target
7
Study locations

NCT06616025 is a Phase 3 study of Peripheral Nerve Injury Upper Limb and Peripheral Nerve Injury (PNI) that is actively recruiting participants, run by Neuraptive Therapeutics. The registered enrollment target is 98 participants. The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06616025, a Phase 3 study of Peripheral Nerve Injury Upper Limb and Peripheral Nerve Injury (PNI), is actively recruiting participants, sponsored by Neuraptive Therapeutics.

RECRUITING
Registry status
Phase 3
Development phase
98 participants
Enrollment target
7
Study locations

Study Summary

NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.

Interventions

  • COMBINATION_PRODUCT NTX-001 (PEG-Fusion)

Study Locations (7)

Missouri

  • Missouri Orthopaedic Institute - Columbia
  • Barnes-Jewish Hospital 1 Barnes Jewish Hospital Plaza St. - St Louis

Florida

  • Orlando Health Orlando Regional Medical Center - Orlando

Illinois

  • University of Chicago - Chicago

Maryland

  • Curtis National Center at MedStar Union Memorial Hospital - Baltimore

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2025-02-10
Est. Completion 2027-04-30
Phase Phase 3

Sponsor

Neuraptive Therapeutics

3 total trials

What the Registry Record Tells You About NCT06616025

The ClinicalTrials.gov registry entry for NCT06616025 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuraptive Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Peripheral Nerve Injury Upper Limb appearing as the primary indexed condition, and to 1 intervention - of which NTX-001 (PEG-Fusion) is the first listed.

NCT06616025 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Missouri, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT06616025 about?

NCT06616025 is a clinical study titled "This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.". NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.

What is the current status of trial NCT06616025?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2025-02-10. Estimated completion is 2027-04-30.

What conditions does trial NCT06616025 study?

This clinical trial studies the following conditions: Peripheral Nerve Injury Upper Limb, Peripheral Nerve Injury (PNI).

What interventions are being tested in trial NCT06616025?

The interventions under investigation include: NTX-001 (PEG-Fusion) (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT06616025?

This trial is sponsored by Neuraptive Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06616025 being conducted?

This trial has 7 study locations across Florida, Illinois, Maryland, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Nerve Injury Upper Limb

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.